Evogene Ltd. (NASDAQ:EVGN) Q4 2025 Earnings Call Transcript March 5, 2026 Evogene Ltd. misses on earnings expectations. Reported EPS is $-0.61 EPS, expectations were $-0.26. Operator: Welcome to ...

Lawmakers introduced measures this week to criminalize AI-generated impersonation, modernize NOAA’s weather radio system and ...

The digital silence of a once-omnipresent fitness star has finally been broken by a tragic announcement that few expected. Dr Stephanie Buttermore, the scientist-turned-influencer who captivated ...

It may seem unconventional, but taking a daily shot of extra-virgin olive oil may actually benefit your health. Olive oil contains monounsaturated fats and antioxidants that combat inflammation and ...

Bharathiar University has been sanctioned a Rs 99.15 lakh DRDO project to develop novel antidotes for toxic organophosphorous compounds. The 3-year project, under the DIA-CoE, will be led by Prof. N ...

Enrollment remains on track in Phase 2 pivotal portion of PYNNACLE trial evaluating rezatapopt as monotherapy in platinum-resistant/refractory ovarian cancer patients with a TP53 Y220C mutation ...

Black Diamond Therapeutics (NASDAQ:BDTX) used a presentation at the 46th annual TD Cowen Healthcare Conference to highlight ...

Reported fourth quarter revenue of $451,000. Reported on track development of the Proteus platform and related R&D programs ...